Aldosterone, Hypertension, and Antihypertensive Therapy: Insights From a General Population

Valentina Cannone1, Alessia Buglioni2, S Jeson Sangaralingham2

  • 1Cardiorenal Research Laboratory, Division of Circulatory Failure, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN; Division of Clinical Medicine, Department of Medicine and Surgery, University of Parma, Parma, Italy.

Insights

Individuals with hypertension have higher aldosterone levels, which increase with more antihypertensive medications. This suggests a relative atrial natriuretic peptide deficiency, impacting hypertension treatment.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Hypertension Research

Background:

  • Hypertension (HTN) is a widespread condition with complex pathophysiology.
  • Aldosterone and atrial natriuretic peptide (ANP) play crucial roles in cardiovascular and renal homeostasis.
  • Understanding the interplay between aldosterone, ANP, and antihypertensive (anti-HTN) medication use is vital for effective HTN management.

Purpose of the Study:

  • To investigate the relationships among aldosterone levels, anti-HTN medication use, clinical profiles, and ANP levels in individuals with HTN.
  • To determine if aldosterone levels differ between hypertensive and normotensive individuals.
  • To examine how the number of anti-HTN medications correlates with aldosterone and ANP levels.

Main Methods:

  • Analysis of a community-based cohort including individuals with and without HTN.
  • Measurement of plasma aldosterone and ANP levels.
  • Stratification of hypertensive participants based on the number of anti-HTN medications used.
  • Evaluation of clinical characteristics, including metabolic and cardiovascular disease prevalence.

Main Results:

  • Hypertensive individuals exhibited significantly higher serum aldosterone levels compared to normotensive participants.
  • Aldosterone levels progressively increased with the number of anti-HTN medications used (0, 1, 2, and ≥3).
  • Higher aldosterone levels were associated with a worse metabolic profile and increased prevalence of cardiovascular, renal, and metabolic diseases. ANP levels were inversely related to aldosterone levels in hypertensive patients.

Conclusions:

  • Aldosterone levels are elevated in individuals with HTN and rise with increased anti-HTN medication use.
  • A relative ANP deficiency may be associated with increasing aldosterone levels and anti-HTN drug use.
  • Targeting aldosterone presents potential pathophysiologic and therapeutic implications for clinical HTN treatment.
Abstract

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
696
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
628
Conservation of Small Populations02:04

Conservation of Small Populations

Small population sizes put a species at extreme risk of extinction due to a lack of variation, and a consequent decrease in adaptability. This weakens the chances of survival under pressures such as climate change, competition from other species, or new diseases. Large populations are more likely to survive pressures such as these, as such populations are more likely to harbor individuals that have genetic variants that are adaptive under new stresses. Small populations are much less...
17.4K
What is Population Genetics?01:25

What is Population Genetics?

A population is composed of members of the same species that simultaneously live and interact in the same area. When individuals in a population breed, they pass down their genes to their offspring. Many of these genes are polymorphic, meaning that they occur in multiple variants. Such variations of a gene are referred to as alleles. The collective set of all the alleles within a population is known as the gene pool.
64.8K
Population Growth00:57

Population Growth

Population size is dynamic, increasing with birth rates and immigration, and decreasing with death rates and emigration. In ideal conditions with unlimited resources, populations can increase exponentially, which plots as a J-shaped growth rate curve of population size against time. This type of curve is characteristic of newly-introduced invasive species, or populations that have suffered catastrophic declines and are rebounding.
28.6K
Antihypertensive Drugs: Vasodilators01:23

Antihypertensive Drugs: Vasodilators

Vasodilators, primarily affecting the smooth muscles within arterial and venous walls, are commonly used for hypertension treatment. Medications such as minoxidil and hydralazine primarily target arteries and arterioles, while sodium nitroprusside acts on arterioles and venules. Minoxidil, functioning as a prodrug, is metabolized by hepatic sulfotransferase into its active form, minoxidil sulfate, after oral administration. This metabolite binds to the sulfonylurea receptor (SUR) component of...
2.2K